$83.97 -0.04 (-0.05%)
2/10/2012 4:01 PM

DaVita, Inc. (NYSE:DVA)

CAPS Rating: 3 out of 5

The Company is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease.

Featured Broker Partners


Advertisement